Statistically developed docetaxel-laden mixed micelles for improved therapy of breast cancer

Docetaxel (DTX) has poor solubility, serious side effects, and multi-drug resistance (MDR) limiting its use in cancer treatment. Hence, the present study aimed to formulate and develop docetaxel mixed micelles (DTX MMs) for breast cancer treatment. DTX MMs were prepared from a mixture of docetaxel,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Smita S. Patil (Autor), Rutuja D. Chougale (Autor), Arehalli S. Manjappa (Autor), John I. Disouza (Autor), Ashok A. Hajare (Autor), Kiran S. Patil (Autor)
Formato: Libro
Publicado: Elsevier, 2022-11-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible